These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37344407)

  • 1. Differences in susceptibility to ADR nephropathy among C57BL/6 substrains.
    Watanabe M; Kakutani M; Hiura K; Sasaki H; Sasaki N
    Exp Anim; 2023 Nov; 72(4):520-525. PubMed ID: 37344407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Characterization of a Novel FVB-
    Watanabe M; Ishii Y; Hashimoto K; Takimoto HR; Sasaki N
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic background strongly influences the transition to chronic kidney disease of adriamycin nephropathy in mice.
    Watanabe M; Hiura K; Sasaki H; Okamura T; Sasaki N
    Exp Anim; 2023 Feb; 72(1):47-54. PubMed ID: 36058845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single amino acid substitution in PRKDC is a determinant of sensitivity to Adriamycin-induced renal injury in mouse.
    Watanabe M; Takahashi Y; Hiura K; Nakano K; Okamura T; Sasaki H; Sasaki N
    Biochem Biophys Res Commun; 2021 Jun; 556():121-126. PubMed ID: 33839407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility to adriamycin-induced hepatotoxicity in mice depends on PRKDC polymorphism.
    Watanabe M; Kakutani M; Ando R; Hiura K; Sasaki H; Okamura T; Sasaki N
    J Vet Med Sci; 2023 Jul; 85(7):702-704. PubMed ID: 37245991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acatalasemic mice are mildly susceptible to adriamycin nephropathy and exhibit increased albuminuria and glomerulosclerosis.
    Takiue K; Sugiyama H; Inoue T; Morinaga H; Kikumoto Y; Kitagawa M; Kitamura S; Maeshima Y; Wang DH; Masuoka N; Ogino K; Makino H
    BMC Nephrol; 2012 Mar; 13():14. PubMed ID: 22443450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
    Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
    Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitro-oleic acid protects against adriamycin-induced nephropathy in mice.
    Liu S; Jia Z; Zhou L; Liu Y; Ling H; Zhou SF; Zhang A; Du Y; Guan G; Yang T
    Am J Physiol Renal Physiol; 2013 Dec; 305(11):F1533-41. PubMed ID: 23486011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic differences in C57BL/6 mouse substrains affect kidney crystal deposition.
    Usami M; Okada A; Taguchi K; Hamamoto S; Kohri K; Yasui T
    Urolithiasis; 2018 Nov; 46(6):515-522. PubMed ID: 29362828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adriamycin-Induced Nephropathy is Robust in N and Modest in J Substrain of C57BL/6.
    Bryant C; Cianciolo R; Govindarajan R; Agrawal S
    Front Cell Dev Biol; 2022; 10():924751. PubMed ID: 35784478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic differences and differentially expressed genes between C57BL/6J and C57BL/6N mice substrains.
    Nemoto S; Kubota T; Ohno H
    PLoS One; 2022; 17(12):e0271651. PubMed ID: 36548271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dietary protein, angiotensin I converting enzyme inhibition and mesangial overload on the progression of adriamycin-induced nephropathy.
    Barretti P; Viero RM; Soares VA
    Braz J Med Biol Res; 1995 Jan; 28(1):39-50. PubMed ID: 7581027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin ameliorates renal lipidosis through the suppression of renal CXCL16 expression in mice with adriamycin-induced nephropathy.
    Wang C; Li Q; Zhen J; Xu Y; Sun S
    Int J Clin Exp Pathol; 2015; 8(12):15696-707. PubMed ID: 26884839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in bone structure and unloading-induced bone loss between C57BL/6N and C57BL/6J mice.
    Sankaran JS; Varshney M; Judex S
    Mamm Genome; 2017 Dec; 28(11-12):476-486. PubMed ID: 28913652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Background but Not Intestinal Microbiota After Co-Housing Determines Hyperoxaluria-Related Nephrocalcinosis in Common Inbred Mouse Strains.
    Ma Q; Grigorescu M; Schreiber A; Kettritz R; Lindenmeyer M; Anders HJ; Steiger S
    Front Immunol; 2021; 12():673423. PubMed ID: 33968083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metallothionein over-expression in podocytes reduces adriamycin nephrotoxicity.
    Yang L; Zheng S; Epstein PN
    Free Radic Res; 2009 Feb; 43(2):174-82. PubMed ID: 19204870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct Age-Specific Effects on Olfactory Associative Learning in C57BL/6 Substrains.
    Chen HL; Chen CF; Huang HB
    Front Behav Neurosci; 2022; 16():808978. PubMed ID: 35185490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CD40-CD154 co-stimulation pathway mediates innate immune injury in adriamycin nephrosis.
    Lee VW; Qin X; Wang Y; Zheng G; Wang Y; Wang Y; Ince J; Tan TK; Kairaitis LK; Alexander SI; Harris DC
    Nephrol Dial Transplant; 2010 Mar; 25(3):717-30. PubMed ID: 19889873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular endothelial cell injury and damage precedes that of podocytes in adriamycin-induced nephropathy.
    Sun YB; Qu X; Zhang X; Caruana G; Bertram JF; Li J
    PLoS One; 2013; 8(1):e55027. PubMed ID: 23359116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with telmisartan and oxacalcitriol suppresses the progression of murine adriamycin nephropathy.
    Jeong KH; Asanuma K; Lydia A; Takagi M; Asao R; Kodama F; Asanuma E; Tomino Y
    Nephron; 2015; 129(2):143-54. PubMed ID: 25661164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.